CN

Cerenome, Inc.

CNSY · Nasdaq

Cerenome, Inc. (CNSY) is a Medical pharmaceuticals company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Cerenome, Inc. in 2026. The next earnings report is expected on October 15, 2026.

Earnings calendar

Next earnings date

15 Oct 2026

In 57 days

EPS estimate

-0.86

Revenue estimate

1.4M

Past earnings

14 Aug 2026
EPS actual
-1.31 (-48.9%)
estimate -0.88
Revenue actual
411.0K (-63.1%)
estimate 1.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
15 May 2026
EPS actual
-1.05 (-23.8%)
estimate -0.85
Revenue actual
1.0M (+5.5%)
estimate 974.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

Cerenome missed consensus estimates in its latest quarter, with EPS of -$1.31 versus an expected -$0.88 and revenue of $411 thousand falling 63.1% short of the $1.11 million estimate. In the prior report, EPS also missed expectations while revenue came in ahead of estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Sector
Healthcare
Industry
Medical pharmaceuticals
Country
United States
Exchange
Nasdaq
CEO
Marc H. Hedrick
Employees
28
IPO date
03 Aug 2026
ISIN
US72941H8060
Website
plustherapeutics.com

Frequently asked questions

When does Cerenome, Inc. (CNSY) next report earnings?

Cerenome, Inc. (CNSY) is scheduled to report earnings on October 15, 2026.

What was Cerenome, Inc.'s most recent earnings date?

Cerenome, Inc. (CNSY) last reported earnings on August 14, 2026.

Where is Cerenome, Inc. stock listed?

Cerenome, Inc. (CNSY) is listed on Nasdaq.